InvestorsHub Logo
Followers 483
Posts 60696
Boards Moderated 18
Alias Born 09/20/2001

Re: Lima4918 post# 189579

Sunday, 04/14/2019 8:57:10 PM

Sunday, April 14, 2019 8:57:10 PM

Post# of 460645
I believe that could be part of the data to tip the scales, but I believe they will want to observe improvement in the current trial that parallels the P2a.

I suspect that the TGA weighed in on trial design and they have the endpoints and biomarkers they want to see confirmed.

The information in the post below confirmed for me that if 2/3 of trial patients start sleeping better and have improved quality of life they will know in real time.

They will have a magic number in mind that is sufficient to confirm the results of the first trial and that could trigger the provisional approval.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148221347



In Peace, In War

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News